Homologous Recombination Deficient-Positive Malignancies Agnostic
1 clinical trials · Condition
◉ Watch Homologous Recombination Deficient-Positive Malignancies Agnostic
| Record | Firm | Date |
|---|---|---|
| Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors (NCT05126433) | Jazz Pharmaceuticals | 2022-03-03 |
Track Homologous Recombination Deficient-Positive Malignancies Agnostic automatically
Every clearance here is in the API, with alerts when new ones post.